Beating out 20+ bidders, Next Phase Solutions and Services, Inc. (Next Phase) is happy to announce the award of a 5-year contract to support the U.S. Food and Drug Administration (FDA) in its mission to modernize and enhance its data capabilities. For FDA, this contract represents a significant leap forward to leverage cutting-edge data techniques to unlock new insights and advance public health outcomes. Building on our contract successes in FDA’s Center for Drug Evaluation and Research and the Centers for Medicare and Medicaid Services, our team will play a critical role in supporting the FDA’s efforts in modernizing and streamlining its approach to Business Intelligence (BI) and data analytics. We will focus on addressing key gaps in data management, infrastructure, and operations while developing data services like curation, data cataloging, engineering, and governance. Additionally, we will support the establishment of cutting-edge AI and analytic services designed to deliver immediate value to the FDA’s scientific and regulatory efforts. By working alongside the FDA’s Office of Digital Transformation (ODT) and Office of Information Management and Technology (OIMT), Next Phase will contribute to building robust data exchange standards, driving innovation, and reinforcing governance across the agency.
This exciting partnership aligns perfectly with our mission to harness the power of data to create meaningful, science-driven change. We look forward to supporting the FDA as it continues to evolve and strengthen its regulatory capabilities for the future. Stay tuned for updates on this groundbreaking contract!
Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $250 annually.
